• EN
    • SV
  • About Us
    • Saniona
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Our history
  • Our Science
    • Science overview
    • Ion channels
    • Publications & posters
    • Partnerships & spinouts
    • The discovery process
  • Our Programs
    • Pipeline overview
    • SAN2668
    • SAN2465
    • SAN2219
    • SAN903
    • Tesofensine
    • Tesomet
    • The development process
  • Patients & Caregivers
    • Indication overview
    • Epilepsy
    • Major depressive disorder
    • Rare diseases
    • Hypothalamic obesity
    • Prader-Willi syndrome
  • Investor Relations
    • Investors overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Latest news
    • Press Releases
    • Interviews
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
  • EN
  • SV
INVESTORS

Events and
Presentations

Saniona Icon blue
  • Overview
  • The Share
    • Share Information
    • Ownership Structure
  • Financial Calendar
  • Reports & Fillings
    • Annual & Quarterly Reports
    • Prospectus
    • Old prospectus
  • Analysts
  • Events and Presentations
  • FAQs
  • Corporate governance
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Shareholder Meetings
    • Nomination Committee
    • Auditors
    • Remuneration Incentive Programs

Saniona Q1 2026 investor call

May 26, 2026 - May 26, 2026

Live Q: Saniona
Add to Google Calendar
  • About Us
    • Saniona
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Our history
  • Our Science
    • Science overview
    • Ion channels
    • Publications & posters
    • Partnerships & spinouts
    • The discovery process
  • Our Programs
    • Pipeline overview
    • SAN2668
    • SAN2465
    • SAN2219
    • SAN903
    • Tesofensine
    • Tesomet
    • The development process
  • Patients & Caregivers
    • Indication overview
    • Epilepsy
    • Major depressive disorder
    • Rare diseases
    • Hypothalamic obesity
    • Prader-Willi syndrome
  • Investor Relations
    • Investors overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Latest news
    • Press Releases
    • Interviews
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
DENMARK

Murervangen 42
DK-2600 Glostrup
Denmark
+45 7070 5225
saniona@saniona.com

CONNECT 
  • Follow
  • Follow
  • Follow

© 2026 Saniona. All rights reserved.

Privacy Policy